Clinical Trials on Malignant Tumors in Japan
Total 412 results
-
Eli Lilly and CompanyCompletedMetastasis | MalignancyJapan
-
Novartis PharmaceuticalsCompletedAdvanced Solid TumorJapan
-
Incyte CorporationCompleted
-
Novartis PharmaceuticalsCompletedAdvanced or Recurrent Solid TumorsJapan
-
Johns Hopkins UniversityMedical University of South Carolina; University of Colorado, Denver; All India... and other collaboratorsCompletedMalignant Distal Biliary ObstructionUnited States, India, Japan, Italy, Netherlands
-
Chinese University of Hong KongTokyo Medical University; Kinki UniversityCompletedMalignant Biliary ObstructionAustralia, Denmark, China, Japan, Belgium
-
Astellas Pharma Global Development, Inc.Merck Sharp & Dohme LLC; Seagen Inc.RecruitingLocally Advanced or Metastatic Malignant Solid TumorsUnited States, Japan, Canada
-
Merck KGaA, Darmstadt, GermanyCompleted
-
SymBio PharmaceuticalsCompleted
-
Takara Bio Inc.Completed
-
Mie UniversityFiverings Co., Ltd.; Shionogi; Takara Bio Inc.; Statcom Co. Ltd.Completed
-
Mie UniversityFiverings Co., Ltd.; Shionogi; Takara Bio Inc.; Statcom Co. Ltd.Unknown
-
AbbVieCompletedGlioblastoma Multiforme | Malignant GliomaJapan
-
Chiba UniversityUnknownPancreatic Tumor | Bile Duct TumorJapan
-
Novartis PharmaceuticalsEckert & Ziegler Radiopharma GmbHRecruiting
-
Daiichi SankyoDaiichi Sankyo, Inc.Active, not recruiting
-
Noile-Immune Biotech, IncRecruiting
-
SanofiCompleted
-
AO Innovation Translation CenterAO Foundation, AO SpineRecruitingMetastatic Spine TumorUnited States, Canada, Hungary, Australia, Germany, Italy, Japan, Netherlands, Singapore, Switzerland
-
Astellas Pharma IncCompleted
-
Kyushu UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompleted
-
Eisai Co., Ltd.Merck Sharp & Dohme LLCCompleted
-
Boehringer IngelheimRecruitingSolid TumorsUnited States, Japan, Canada
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompleted
-
Array Biopharma, now a wholly owned subsidiary...CompletedAdvanced Solid TumorJapan
-
Mie UniversityCompleted
-
Kyowa Kirin Co., Ltd.RecruitingAdvanced or Metastatic Solid TumorsJapan
-
AstraZenecaCompletedAdvanced Solid Malignancies | Malignant LymphomaUnited Kingdom, Japan
-
Astellas Pharma IncCompletedLocally Advanced (Unresectable) or Metastatic Solid Tumor MalignanciesJapan
-
PfizerCompletedPancreatic Neuroendocrine TumorsJapan
-
AstraZenecaCompleted
-
Novartis PharmaceuticalsActive, not recruitingSomatostatin Receptor-positive Neuroendocrine TumorJapan
-
Eisai Co., Ltd.Completed
-
Novartis PharmaceuticalsCompletedCancer | Advanced Solid TumorJapan
-
National Cancer Center, JapanRecruitingRare Malignant NeoplasmTaiwan, Malaysia, Japan, Philippines, Vietnam, Thailand, Korea, Republic of
-
zr Pharma & GmbHCompletedAdvanced Solid TumorJapan
-
Novartis PharmaceuticalsCompletedGastrointestinal Stromal TumorsJapan
-
ShionogiMerck Sharp & Dohme LLCRecruitingSolid TumorsUnited States, Japan
-
Aichi Medical UniversityUnknown
-
Boehringer IngelheimCompleted
-
ASLAN PharmaceuticalsCompletedAdvanced or Metastatic Solid Tumors | Advanced or Metastatic Biliary Tract CancerJapan
-
AstraZenecaCompletedPart A and B: Advanced Solid Malignancies | Part C: Malignant MesotheliomaJapan
-
Merck KGaA, Darmstadt, GermanyCompletedSolid TumorsKorea, Republic of, Taiwan, Japan
-
Daiichi Sankyo Co., Ltd.AstraZenecaCompletedMalignant Neoplasm of BreastJapan
-
Novartis PharmaceuticalsCompleted
-
BayerCompletedAdvanced or Recurrent Solid Tumor Harboring an NTRK Gene FusionJapan
-
GlaxoSmithKlineCompleted
-
Sumitomo Pharma Co., Ltd.CompletedHepatocellular Carcinoma | Advanced Solid TumorsJapan
-
AbbVieCompletedAdvanced Solid TumorsJapan